Life science companies are solving big problems with home-grown clusters, racks of blades, and gangs of PCs working overtime.
By Salvatore Salamone
Genomics Collaborative and Ardais take the lead in using IT to bring human tissue banking into the era of clinical genomics.
By Mark D. Uehling
Strategic Insights: Clinical Trials
Implementation by clinical sites is lumbering along at an unimpressive rate. Here's what must be done to speed things up.
By Nicholas Richards
Low adoption rates of e-clinical trial technology can't be blamed on external market dynamics alone. Biopharmas must face four inhibitors within their own organizations.
By Kenneth Getz
Adoption may be lagging at the enterprise level, but there's a stalwart group of biopharmas making EDC happen. Here's how they're doing it.
By Paul Bleicher
Company to Watch
GenPath takes a novel approach to cancer research.
Michael Liebman of Windber Research Institute on a top-down approach to systems biology.
Pharma's Genomic Harvest
How Pfizer plans to meet its goal of 20 major new drug applications over five years.
News & Analysis
EDC Shootout at the Data Corral
Iconix Seals Two Major Tox Deals
DeCODE's Cardiac Gene Claim Causes FLAP
LabCorp Licenses Junk DNA Patent
Neural Nets Decipher Brain Tumor Data
CNIO: Profiles in Carcinogenesis
Rosetta Takes Merck's IT Reins
Biosapiens Born in Europe
First Base | Kevin Davies
Another view of the war of the bases.
Inside the Box | Chris Dagdigian
How to juggle cluster software licenses.
Nothing Ventured | Michael A. Greeley
Insights|Outlook | Zachary Zimmerman with Sue Flood & Edward D. Helton
Fully Equipped | Julia Boguslavsky
Nanolithography comes to bioarrays.
The Russell Transcript | John Russell
IBM now melds healthcare, life sciences, and IT.